Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Dupuis-Girod S, Ambrun A, Decullier E, Samson G, Roux A, Fargeton AE, Rioufol C, Schwiertz V, Disant F, Chapuis F, Donazzolo Y, Paintaud G, Edery P, Faure F. Dupuis-Girod S, et al. Among authors: donazzolo y. MAbs. 2014 May-Jun;6(3):794-9. doi: 10.4161/mabs.28025. Epub 2014 Jan 30. MAbs. 2014. PMID: 24481211 Free PMC article. Clinical Trial.
Evaluation of the effects of therapeutic and supratherapeutic doses of agomelatine on the QT/QTc interval: a phase I, randomized, double-blind, placebo-controlled and positive-controlled, crossover thorough QT/QTc study conducted in healthy volunteers.
Donazzolo Y, Latreille M, Caillaud MA, Mocaer E, Seguin L. Donazzolo Y, et al. J Cardiovasc Pharmacol. 2014 Nov;64(5):440-51. doi: 10.1097/FJC.0000000000000136. J Cardiovasc Pharmacol. 2014. PMID: 24977347 Clinical Trial.
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Ibarra A, et al. Among authors: donazzolo y. Gut Microbes. 2018;9(3):236-251. doi: 10.1080/19490976.2017.1412908. Epub 2018 Feb 8. Gut Microbes. 2018. PMID: 29227175 Free PMC article. Clinical Trial.
After the London tragedy, is it still possible to consider Phase I is safe?
Sibille M, Donazzolo Y, Lecoz F, Krupka E. Sibille M, et al. Among authors: donazzolo y. Br J Clin Pharmacol. 2006 Oct;62(4):502-3. doi: 10.1111/j.1365-2125.2006.02740.x. Epub 2006 Jul 3. Br J Clin Pharmacol. 2006. PMID: 16817849 Free PMC article. No abstract available.
Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial.
Le Lamer S, Paradis S, Rahmouni H, Chaimbault C, Michaud M, Culcasi M, Afxantidis J, Latreille M, Berna P, Berdeaux A, Pietri S, Morin D, Donazzolo Y, Abitbol JL, Pruss RM, Schaller S. Le Lamer S, et al. Among authors: donazzolo y. J Transl Med. 2014 Feb 7;12:38. doi: 10.1186/1479-5876-12-38. J Transl Med. 2014. PMID: 24507657 Free PMC article. Clinical Trial.
39 results